P A Seymour

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

David W. Schulz, Robert S. Mansbach, Jeffrey Sprouse et al. · Proceedings of the National Academy of Sciences · 1996 · 378 citations · Full text

Social Sciences, Molecular Pharmacology, Crf Receptors +17

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 320 citations

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

C J Schmidt, Douglas S. Chapin, J. Cianfrogna et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 284 citations

Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.

Stafford McLean, Alan H. Ganong, P A Seymour et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 222 citations

Reduction of Brain Kynurenic Acid Improves Cognitive Function

Rouba Kozak, Brian Campbell, Christine A. Strick et al. · Journal of Neuroscience · 2014 · 172 citations · Full text

Synaptic Transmission, Neurotransmitter, Clinical Neuroscience +20